Chartwell Investment Partners LLC Lowers Stock Holdings in Integer Holdings Co. (NYSE:ITGR)

Chartwell Investment Partners LLC cut its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 10.1% during the third quarter, Holdings Channel reports. The firm owned 47,033 shares of the medical equipment provider’s stock after selling 5,287 shares during the quarter. Chartwell Investment Partners LLC’s holdings in Integer were worth $6,115,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in ITGR. Janney Montgomery Scott LLC lifted its holdings in Integer by 7.8% during the 1st quarter. Janney Montgomery Scott LLC now owns 10,013 shares of the medical equipment provider’s stock worth $1,168,000 after buying an additional 725 shares in the last quarter. Texas Permanent School Fund Corp raised its stake in shares of Integer by 1.3% in the first quarter. Texas Permanent School Fund Corp now owns 29,167 shares of the medical equipment provider’s stock valued at $3,403,000 after acquiring an additional 377 shares in the last quarter. SG Americas Securities LLC boosted its holdings in Integer by 43.5% in the first quarter. SG Americas Securities LLC now owns 8,394 shares of the medical equipment provider’s stock valued at $979,000 after purchasing an additional 2,544 shares during the period. Headlands Technologies LLC acquired a new position in Integer during the 1st quarter worth $106,000. Finally, QRG Capital Management Inc. increased its holdings in Integer by 1.1% during the 1st quarter. QRG Capital Management Inc. now owns 31,368 shares of the medical equipment provider’s stock worth $3,660,000 after purchasing an additional 332 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on ITGR shares. Citigroup lifted their price objective on Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. Benchmark boosted their price target on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. Truist Financial reduced their price objective on shares of Integer from $150.00 to $147.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Bank of America boosted their target price on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. Finally, KeyCorp raised their price target on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research note on Tuesday, October 15th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $139.75.

Integer Price Performance

Shares of ITGR opened at $139.60 on Tuesday. The firm has a fifty day moving average price of $128.43 and a 200 day moving average price of $121.87. The stock has a market cap of $4.68 billion, a PE ratio of 43.05, a price-to-earnings-growth ratio of 1.96 and a beta of 1.09. Integer Holdings Co. has a 1-year low of $84.75 and a 1-year high of $139.65. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. During the same quarter last year, the business posted $1.27 EPS. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Integer Holdings Co. will post 5.33 EPS for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.